Division of Advanced Research on Human Immunological Diseases
To quickly achieve proof-of-concept in humans for new drug candidates, we'll leverage Chiba University Hospital's strengths as a clinical research core hospital. This will allow us to establish a system for conducting clinical trials, including first-in-human studies, specifically for human immune diseases (e.g., iPS-NKT cell therapy).
Our goal is to establish an AI-driven system for the real-time, integrated sharing of comprehensive basic and clinical evidence pertaining to human immunology and associated diseases.
To maximize the value of human samples collected during clinical research and trials, we're implementing a new framework that will allow for their efficient use in both basic and clinical immunology studies. This system will also be made accessible to other universities and research institutions.
We are working to establish a collaborative system, in partnership with institutions such as the University of Tokyo and Nagasaki University, as part of AMED’s initiative "Japan Initiative for World-leading Vaccine Research and Development Centers". This system will enable the conduct of human challenge trials, which are currently unprecedented in Japan, to effectively demonstrate vaccine efficacy.
Division of Technology Development on Human Immunological Diseases
We are establishing this division as a shared resource to provide scientific insights, drive advanced technological development, and offer informatics support, all aimed at enhancing our comprehension of the human immune system. It will offer cutting-edge technological resources such as single-cell technology, next-generation blood testing platforms, and next-generation imaging.
We'll set up joint research and development chairs with leading equipment manufacturers in this division. This arrangement will allow us to outsource the operation and maintenance of cutting-edge instruments to the manufacturers. It will also facilitate a system where their highly skilled engineers and our researchers can collaborate on groundbreaking analysis and technology development. We'll then extend these effective practices across the university.
In partnership with the Chiba University Data Science Core (DSC), we're setting up an AI Clinical Research Support Lab. This lab will harness AI to offer end-to-end support for clinical research, covering everything from initial design to bioinformatics analysis.
